Correction: Microneutralization assay titres correlate with protection against seasonal Influenza H1N1 and H3N2 in children (PLoS ONE (2016) 10:6 (e0131531) DOI: 10.1371/journal.pone.0131531);Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Verschoor, Chris P ^a,b,c   Singh, Pardeep ^b   Russell, Margaret L ^d   Bowdish, Dawn M E ^a,b,c   Brewer, Angela ^e   Cyr, Louis ^e   Ward, Brian J ^e   Loeb, Mark ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; INFLUENZA VACCINE; VIRUS ANTIBODY; HEMAGGLUTININ, HUMAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; COHORT ANALYSIS; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN EXPERIMENT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); MICRONEUTRALIZATION ASSAY; NORMAL HUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; VACCINATION; VIRUS NEUTRALIZATION; ALBERTA; ANTIBODY PRODUCTION; BLOOD; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); MANITOBA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS;

ORTHOMYXOVIRIDAE;

ADOLESCENT; ALBERTA; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MANITOBA; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 84938929930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163830     Document Type: Erratum

References (15)

1. Grund S, Adams O, Wählisch S, Schweiger B. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. J Virol Methods. 2011; 171: 369-373. doi: 10.1016/j.jviromet.2010.11.024 PMID: 21146560
2. Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011; 30: 1081-1085. doi: 10.1097/INF.0b013e3182367662 PMID: 21983214
3. Paccalin M, Plouzeau C, Bouche G, Guillard O, Beby-Defaux A, Mauco G, et al. Lack of correlation between nutritional status and seroprotection against influenza in a long term care facility. Scand J Infect Dis. 2006; 38: 894-897. doi: 10.1080/00365540600749984 PMID: 17008234
4. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess Winch Engl. 2010; 14: 115-192. doi: 10.3310/hta14550-03
5. Herrera MT, Gonzalez Y, Juárez E, Hernández-Sánchez F, Carranza C, Sarabia C, et al. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees. BMC Infect Dis. 2013; 13: 544. doi: 10.1186/1471-2334-13-544 PMID: 24238117
6. Hsu JP, Zhao X, Chen MI-C, Cook AR, Lee V, Lim WY, et al. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore. BMC Infect Dis. 2014; 14: 414. doi: 10.1186/1471- 2334-14-414 PMID: 25066592
7. Cheng L-W, Huang S-W, Huang L-M, Chang L-Y, Shao P-L, Kiang D, et al. Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine. J Virol Methods. 2012; 182: 43-49. doi: 10.1016/j.jviromet.2012.03.004 PMID: 22433514
8. McCullers JA, Huber VC. Correlates of vaccine protection from influenza and its complications. Hum Vaccines Immunother. 2012; 8: 34-44. doi: 10.4161/hv.8.1.18214
9. Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJD, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010; 303: 943-950. doi: 10.1001/jama.2010.250 PMID: 20215608
10. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. N Engl J Med. 2009; 360: 2605-2615. doi: 10.1056/NEJMoa0903810 PMID: 19423869
11. Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Serum 25-hydroxyvitamin d level and influenza vaccine immunogenicity in children and adolescents. PloS One. 2014; 9: e83553. doi: 10.1371/journal.pone.0083553 PMID: 24427274
12. Yam KK, Gupta J, Brewer A, Scheifele DW, Halperin S, Ward BJ, et al. Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine. Clin Vaccine Immunol CVI. 2013; 20: 459-467. doi: 10.1128/CVI.00619-12
13. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990; 9: 811-818. PMID: 2218183
14. Tsang TK, Cauchemez S, Perera RAPM, Freeman G, Fang VJ, Ip DKM, et al. Association between antibody titers and protection against influenza virus infection within households. J Infect Dis. 2014; 210: 684-692. doi: 10.1093/infdis/jiu186 PMID: 24676208
15. Ng S, Fang VJ, Ip DKM, Chan K-H, Leung GM, Peiris JSM, et al. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J Infect Dis. 2013; 208: 1320-1324. doi: 10.1093/infdis/jit372 PMID: 23908481